Horizon Therapeutics PLC (NASDAQ:HZNP)
| 115.67 Delayed Data As of Sep 29 |  0.00 / 0.00%Today’s Change | 60.03 Today|||52-Week Range 115.87 | +1.64% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 757.0M | 1.0B | 1.1B | 1.2B | |
| Cost of Goods Sold | 60.0M | 173.9M | 262.9M | 146.6M | ||
| Depreciation And Amortization | 138.3M | 221.8M | 283.4M | 275.7M | ||
| Operating Expenses | Gross Income | 558.7M | 650.4M | 510.0M | 785.3M | |
| General Expenses | 436.6M | 651.5M | 902.3M | 769.5M | ||
| Research And Development | 38.8M | 60.2M | 225.0M | 82.8M | ||
| Total Operating Expenses | 634.9M | 1.0B | 1.4B | 1.2B | ||
| Non-Operating Expenses | Operating Income | 122.2M | -1.1M | -392.4M | 15.8M | |
| Extraordinary Credit | 0.00 | 2.5M | 0.00 | 0.00 | ||
| Extraordinary Charge | -154.4M | -148.6M | -978.0K | -56.1M | ||
| Interest Expense On Debt | 69.9M | 86.6M | 126.5M | 121.7M | ||
| Other Expenses | -30.6M | 5.7M | 6.6M | 42.8M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -132.7M | -228.1M | -513.3M | -119.1M | |
| Income Taxes | -172.2M | -61.3M | -102.7M | -45.0M | ||
| Net Income | 39.5M | -166.8M | -410.5M | -74.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 148.8M | 160.7M | 163.1M | 166.2M | |
| Shares To Calculate EPS Diluted | 155.9M | 160.7M | 163.1M | 166.2M | ||
| Earnings Per Share | EPS | $0.25 | -$1.04 | -$2.52 | -$0.45 | |
| EPS Diluted | $0.25 | -$1.04 | -$2.52 | -$0.45 | ||
